Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Purevax RCPCh FeLV   
Auth. number : EU/2/04/047
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AX - Other immunologicals
Chemical substance: QI06AX - Other immunologicals
(See WHO ATCvet Index)
Indication: Vaccine against feline viral rhinotracheitis, feline calicivirosis, chlamydiosis, feline panleucopenia and feline leukaemia.
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, F-69007 Lyon, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/02/2005 Centralised - Authorisation EMEA/V/C/85 (2005)470 of 23/02/2005
24/07/2005 Centralised - Variation (no change in Commission Decision) EMEA/V/C/85/I/1
25/01/2008 Centralised - Variation EMEA/V/C/85/II/2, 3, 4 (2007)338 of 22/01/2008
23/09/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/85/II/5
17/02/2009 Centralised - Variation EMEA/V/C/85/II/6 (2009)1100 of 13/02/2009
19/01/2010 Centralised - Renewal EMEA/V/C/85/R/7 (2010)122 of 15/01/2010